GlassScriptPhysician profile
Sarah Cullen
NPI 1831684869
$6,402.34
in general payments reported to CMS, 2019-2025
35 companies · $577 in 2025
The $577 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $739 · 2020: $554 · 2021: $2,093 · 2022: $914 · 2023: $645 · 2024: $879 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,085 · Education: $16.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,084.56 |
| Education | $16.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kairos Surgical INC | $1,214.99 | 2021 | |
| Stryker Corporation | $1,157.83 | 2019-2025 | Augment Injectable, Ortholoc 3di, Fuseforce |
| Integra Lifesciences Corporation | $725.46 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $518.17 | 2019-2025 | Stravix, Grafix Pl, Stravix Pl |
| Medartis INC. | $490.64 | 2019-2020 | |
| Organogenesis INC. | $337.20 | 2019-2025 | Affinity |
| Treace Medical Concepts, INC. | $215.36 | 2022-2025 | |
| Bone Support INC. | $212.90 | 2024 | Ceramentbone Void Filler, Cerament G |
| Alafair Biosciences, INC. | $185.67 | 2024 | Versawrap |
| Peerless Surgical INC. | $144.36 | 2022-2024 | |
| Abbvie INC. | $115.53 | 2021-2025 | Dalvance |
| Ossio INC | $111.53 | 2022 | |
| Nevro Corp. | $102.97 | 2022-2024 | Senza |
| Bioventus LLC | $94.39 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $78.32 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $76.94 | 2021 | |
| Averitas Pharma INC. | $61.32 | 2023-2025 | Qutenza |
| Celularity INC. | $58.00 | 2019 | |
| Kuros Biosciences USA, INC | $51.75 | 2022-2023 | |
| Sebela Pharmaceuticals INC. | $48.93 | 2021-2022 | |
| Access Pro Medical, LLC | $46.25 | 2023 | Matriderm |
| Grt US Holding, INC. | $44.14 | 2021-2022 | |
| Kci USA, INC. | $42.14 | 2020-2022 | |
| Globus Medical, INC. | $40.99 | 2025 | Senza |
| Biowound Solutions, INC. | $38.32 | 2025 | Bio-Connekt |
| Horizon Therapeutics Plc | $32.50 | 2021-2023 | Krystexxa |
| Lifenet Health | $28.90 | 2025 | Theragenesis Wound Matrix |
| Paratek Pharmaceuticals, INC. | $21.14 | 2024 | Nuzyra |
| Axogen | $19.24 | 2019 | |
| Orthopediatrics Corp. | $17.86 | 2025 | |
| Next Science LLC | $15.17 | 2023 | Surgx, Blastx, Xperience |
| Innovation Technologies INC | $15.04 | 2025 | Irrisept |
| Zimmer Biomet Holdings, INC. | $14.00 | 2021 | |
| Convatec INC. | $13.02 | 2023 | |
| Polynovo North America LLC | $11.37 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Cullen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.